As with many diseases, our knowledge of type 2 diabetes mellitus is increasing through research. Recent developments include the use of new treatments and guidelines in clinical practice. There has been an update to the IDF guidelines concerning glucagon-like peptide-1 agonist (GLP-1 agonists), dipeptidyl peptidase-4 inhibitor (DPP-4 inhibitors) are now used in the treatment of diabetes, and sodium glucose co-transporter 2 (SGLT-2) inhibitors are being investigated for this use.
The Diabetes Knowledge Centre aims to provide endocrinologists and other healthcare professionals with the latest information in the area of type 2 diabetes mellitus. Containing information on complications, HbA1C levels, incretins, screening and diagnosis, as well as treatment and management options, this interactive resource is essential viewing for endocrinologists and other healthcare professionals with an interest in diabetes.
The Men’s Health Knowledge Centre is a resource for healthcare professionals contains a latest updates section with monthly editorials of recently published articles in the area of hypogonadism (low testosterone), and the effect this hormone deficiency has on has on hypogonal men. This clear and concise information concerning this endocrine disorder makes this resource essential regular viewing for endocrinologists.
In addition to this reguarally updated content, sections detailing the diagnosis, treatment and monitoring of men with erectile dysfunction (ED) or hypogonadism (low testosterone) are also available. This extensive resource aims to provide endocrinologists and other healthcare professionals with a better understanding of the epidemiology and etiology of these diseases and provide information about available treatment options for these men.
This observational study is aimed at assessing insulin secretion and sensitivity by the use of a mathematical modeling from oral glucose tolerance test in subjects with liver cirrhosis undergoing orthotopic liver transplantation (OLT), before and at various time points after OLT.